Insider Trades
Common-stock transactions that officers, directors and 10% owners of healthcare companies report to the SEC on Form 4, from 2006 to today, newest first.
Insider filings are public records and are not a recommendation.
Results
25+ transactions, newest first
| Date | Insider | Relationship | Company | Transaction | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Schneeberger Daniel; ADAR1 Capital Management, LLC | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 8,340 | $1.29 | $10,758.60 | 892,101Indirect, See Footnote | Form 4 filed 16 Sep 2026, on sec.gov (opens in a new tab)Filed 16 Sep 2026 | |
| Schneeberger Daniel; ADAR1 Capital Management, LLC | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 54,256 | $1.30 | $70,532.80 | 883,761Indirect, See Footnote | Form 4 filed 16 Sep 2026, on sec.gov (opens in a new tab)Filed 16 Sep 2026 | |
| Schneeberger Daniel; ADAR1 Capital Management, LLC | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 28,505 | $1.29 | $36,771.45 | 829,505Indirect, See Footnote | Form 4 filed 16 Sep 2026, on sec.gov (opens in a new tab)Filed 16 Sep 2026 | |
| Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 2 | $1.55 | $3.10 | 75,019Indirect, By Vivo Opportunity Cayman Fund, L.P. | Form 4 filed 16 Jul 2026, on sec.gov (opens in a new tab)Filed 16 Jul 2026 | |
| Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 19 | $1.55 | $29.45 | 743,057Indirect, By Vivo Opportunity Fund Holdings, L.P. | Form 4 filed 16 Jul 2026, on sec.gov (opens in a new tab)Filed 16 Jul 2026 | |
| Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 1,389 | $1.55 | $2,152.95 | 75,017Indirect, By Vivo Opportunity Cayman Fund, L.P. | Form 4 filed 16 Jul 2026, on sec.gov (opens in a new tab)Filed 16 Jul 2026 | |
| Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 13,761 | $1.55 | $21,329.55 | 743,038Indirect, By Vivo Opportunity Fund Holdings, L.P. | Form 4 filed 16 Jul 2026, on sec.gov (opens in a new tab)Filed 16 Jul 2026 | |
| ADAR1 Capital Management, LLC; Schneeberger Daniel | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 1,000 | $1.56 | $1,560 | 801,000Indirect, See Footnote | Form 4 filed 17 Jul 2026, on sec.gov (opens in a new tab)Filed 17 Jul 2026 | |
| Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 493 | $1.55 | $764.15 | 73,628Indirect, By Vivo Opportunity Cayman Fund, L.P. | Form 4 filed 16 Jul 2026, on sec.gov (opens in a new tab)Filed 16 Jul 2026 | |
| Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 4,882 | $1.55 | $7,567.10 | 729,277Indirect, By Vivo Opportunity Fund Holdings, L.P. | Form 4 filed 16 Jul 2026, on sec.gov (opens in a new tab)Filed 16 Jul 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 147 | $1.55 | $227.85 | 73,135Indirect, By Vivo Opportunity Cayman Fund, L.P. | Form 4 filed 2 Jul 2026, on sec.gov (opens in a new tab)Filed 2 Jul 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 1,460 | $1.55 | $2,263 | 724,395Indirect, By Vivo Opportunity Fund Holdings, L.P. | Form 4 filed 2 Jul 2026, on sec.gov (opens in a new tab)Filed 2 Jul 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 398 | $1.55 | $616.90 | 72,988Indirect, By Vivo Opportunity Cayman Fund, L.P. | Form 4 filed 2 Jul 2026, on sec.gov (opens in a new tab)Filed 2 Jul 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 3,946 | $1.55 | $6,116.30 | 722,935Indirect, By Vivo Opportunity Fund Holdings, L.P. | Form 4 filed 2 Jul 2026, on sec.gov (opens in a new tab)Filed 2 Jul 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 55 | $1.54 | $84.70 | 72,590Indirect, By Vivo Opportunity Cayman Fund, L.P. | Form 4 filed 2 Jul 2026, on sec.gov (opens in a new tab)Filed 2 Jul 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 545 | $1.54 | $839.30 | 718,989Indirect, By Vivo Opportunity Fund Holdings, L.P. | Form 4 filed 2 Jul 2026, on sec.gov (opens in a new tab)Filed 2 Jul 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 2,982 | $1.52 | $4,532.64 | 72,535Indirect, By Vivo Opportunity Cayman Fund, L.P. | Form 4 filed 10 Jun 2026, on sec.gov (opens in a new tab)Filed 10 Jun 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 29,518 | $1.52 | $44,867.36 | 718,444Indirect, By Vivo Opportunity Fund Holdings, L.P. | Form 4 filed 10 Jun 2026, on sec.gov (opens in a new tab)Filed 10 Jun 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 5,045 | $1.57 | $7,920.65 | 69,553Indirect, By Vivo Opportunity Cayman Fund, L.P. | Form 4 filed 10 Jun 2026, on sec.gov (opens in a new tab)Filed 10 Jun 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 49,966 | $1.57 | $78,446.62 | 688,926Indirect, By Vivo Opportunity Fund Holdings, L.P. | Form 4 filed 10 Jun 2026, on sec.gov (opens in a new tab)Filed 10 Jun 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 618 | $1.57 | $970.26 | 64,508Indirect, By Vivo Opportunity Cayman Fund, L.P. | Form 4 filed 10 Jun 2026, on sec.gov (opens in a new tab)Filed 10 Jun 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 6,125 | $1.57 | $9,616.25 | 638,960Indirect, By Vivo Opportunity Fund Holdings, L.P. | Form 4 filed 10 Jun 2026, on sec.gov (opens in a new tab)Filed 10 Jun 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 714 | $1.55 | $1,106.70 | 63,890Indirect, By Vivo Opportunity Cayman Fund, L.P. | Form 4 filed 10 Jun 2026, on sec.gov (opens in a new tab)Filed 10 Jun 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 7,069 | $1.55 | $10,956.95 | 632,835Indirect, By Vivo Opportunity Fund Holdings, L.P. | Form 4 filed 10 Jun 2026, on sec.gov (opens in a new tab)Filed 10 Jun 2026 | |
| Vivo Opportunity, LLC; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity Cayman Fund, L.P. | 10% owner | InMed Pharmaceuticals Inc.INM | BuyP · Open-market or private purchase | 2,095 | $1.52 | $3,184.40 | 63,176Indirect, By Vivo Opportunity Cayman Fund, L.P. | Form 4 filed 10 Jun 2026, on sec.gov (opens in a new tab)Filed 10 Jun 2026 |
Source: SEC EDGAR Form 4 filings and the SEC Insider Transactions Data Sets (2006 onward). Each row links to its Form 4 filing. Values are shares times the reported price. Nothing here is investment advice.